Retinoic-acid receptor β expression in melanocytes

European Journal of Dermatology

Volumn 14, Issue 1, 2004, Pages 19-23

  Boehm, Nelly ^a   Samama, Brigitte ^a   Cribier, Bernard ^b   Rochette Egly, Cécile ^c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Immunocytochemistry; Melanocyte; Melanoma; RAR ; Retinoic acid receptors; RXR

Indexed keywords

RECEPTOR SUBUNIT; RETINOIC ACID RECEPTOR BETA; RETINOID X RECEPTOR;

ARTICLE; CONTROLLED STUDY; EPIDERMIS; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEBACEOUS GLAND;

BIOPSY, NEEDLE; CASE-CONTROL STUDIES; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTES; MELANOMA; RECEPTORS, RETINOIC ACID; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0442313536     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997; 53: 358-88.
2. Levine N, Moon TE, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS. Trial of retinol and isotretinoin in skin cancer prevention: a randomised, double-blind, controlled trial. Southwest Skin Cancer Prevention Study group. Cancer Epidemiol Biomarkers Prev 1997; 6: 957-61.
3. Chambon P. The molecular and genetic dissection of the retinoid signalling pathway. Recent Prog Horm Res 1995; 50: 317-32.
4. Elder JT, Fisher GJ, Zhang QY, Eisen D, Krust A, Kastner P, Chambon P, Voorhees JJ. Retinoic acid receptor gene expression in human skin. J Invest Dermatol 1991; 96: 425-33.
5. Elder JT, Aström A, Petterson U, Tavakkol A, Griffiths CE, Krust A, Kastner P, Chambon P, Voorhees JJ. Retinoid acid receptors and binding proteins in human skin. J Invest Dermatol 1992; 98: 36S-41S.
6. Torma H, Rollman O, Vahlquist A. Detection of mRNA transcripts for retinoic acid, vitamin D3, and thyroid hormone (c-erb-A) nuclear receptors in human skin using reverse transcription and polymerase chain reaction. Acta Derm Venereol 1993; 73: 102-7.
7. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996; 10: 1002-13.
8. Rochette-Egly C, Gaub MP, Lutz Y, Ali S, Scheuer I, Chambon P. Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol 1992; 12: 2197-206.
9. Rochette-Egly C, Lutz Y, Pfister V, Heyberger S, Scheuer I, Chambon P, Gaub MP. Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. Biochem Biophys Res Commun 1994; 204: 525-36.
10. Xu XC, Wong WYL, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM, Lotan R. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001; 61: 4306-10.
11. Crowe DL, Hu L, Gudas LJ, Rheinwald JG. Variable expression of retinoic acid receptor (RAR beta) mRNA in human oral and epidermal keratinocytes; relation to keratin 19 expression and keratinization potential. Differentiation 1991; 48: 199-208.
12. Geisen C, Denk C, Gremm B, Baust C, Karger A, Bollag W, Schwarz E. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 1997; 57: 1460-7.
13. Zhang W, Rashid A, Wu H, Xu XC. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant oesophageal tissues. J Cancer Res Clin Oncol 2001; 127: 237-42.
14. Zou CP, Hong WK, Lofan R. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squomous carcinoma cells. Differentiation 1999; 64: 123-32.
15. Clifford JL, Petkovich M, Chombon P, Lotan R. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol Endocrinol 1990; 4: 1546-55.
16. Spanjaard RA, Sugawara A, Ikeda M, Chin WW. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melonoma cells. J Biol Chem 1995; 270: 17429-36.
17. Xioo Y, Desai D, Quick TC, Miles RM. Control of retinoic acid receptor expression in mouse melan by cyclic AMP. J Cell Physiol 1996; 167: 413-21.
18. Desai SH, Boskovic G, Eastham L, Dawsan M, Niles RM. Effect of Receptor-Selective Retinoids on Growth and Differentiation Pathways in Mouse Melanoma Cells. Biochem Pharmacol 2000; 59: 1265-75.
19. Reichrath J, Münssinger T, Kerber A, Rochette-Egly C, Chambon P, Bahmer FA, Baum HP. In situ detection of retinoid-X receptor expression in normal and psoriatic human skin. Br J Dermatol 1995; 133: 168-75.
20. Reichrath J, Mittmann M, Kamrodt J, Muller SM. Expression of retinoid-X receptors (-α,-β,-γ) and retinoic acid receptors (-α,-β,-γ) in normal human skin: an immunohistological evaluation. Histochem J 1997; 29: 127-33.
21. Chopellier B, Mark M, Messaddeq N, Calléja C, Warot X, Brocard J, Gérard C, Li M, Metzger D, Ghyselinck NB, Chambon P. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J 2002; 21: 3402-13.
22. Boehm N, Château D, Rochette-Egly C. Retinoid receptors in rat vaginal and uterine epithelia: changes with ovarian steroids. Mol Cell Endocrinol 1997; 132: 101-8.
23. Billoni N, Gautier B, Mahe YF, Bernard BA. Expression of retinoid nuclear receptor superfamily members in human hair follicles and its implication in hair growth. Acta Derm Venereol 1997; 77: 350-5.
24. Clifford JL, Chiba H, Sobieszczuk D, Chambon P. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J 1996; 15: 4142-55.
25. Li M, Chiba H, Warot X, Messaddeq N, Gérard C, Chambon P, Metzger D. RXRα ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001; 128: 675-88.
26. Moldvay J Grignon Y, Vignaud JM, Rochette-Egly C, Martinet Y, Martinet N. Down-regulation of retinoids receptors in malignant mesothelioma. Eur Resp J 2001; 18: 17s (Abstract n° 237).
27. Arapshian A, Kuppumbatti YS, Mira-y-Lopez R. Methylation of conserved CpG sites neighbouring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene 2000; 19: 4066-70.
28. Suh YA, Lee HY, Virmani A, Wong J, Mann KK, Miller WH, Gazdar A, Kurie JM. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 ocetylation in lung concer cell lines. Cancer Res 2002; 62: 3945-9.
29. Salh B, Marotta A, Wagey R, Sayed M, Pelech S. Dysregulation of phosphatidylinasitol 3-kinase and downstream effectors in human breast cancer. Int J Cancer 2002; 98: 148-54.
30. Tari AM, Lim SJ, Hung MC, Esteva FJ, Lopez-Berestein G. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene 2002; 21: 5224-3
31. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. Hyperoctivation af MARK induces loss of ERa expression in breast cancer cells. Mol Endocrinol 2001; 15: 1344-59.
32. Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, Louis G, Moses M, Arbiser JL. Malignant transformation of melonocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signalling. J Biol Chem 2003; 278: 9790-7.
33. Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR degradation and transactivotion. EMBO J 2002; 21: 3760-9.
34. Gianni M, Tarrade A, Nigro EA, Garattini E, Rochette-Egly C. The AF-1 and AF-2 domains of RARγ2 and RXRα cooperate for triggering the transactivation and the degradation of RARγ2/RXRα heterodimers. J Biol Chem 2003; 278: 34458-66.
35. Schadendorf D, Worm M, Jurkovsky K, Dippel E, Reichert U, Czarnetzki BM. Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. Recent Results Cancer Res 1995; 139: 183-93.
36. Gianni M, Kopf E, Bastien J, Oulad-Abdelghani M, Garattini E, Chambon P, Rochette-Egly C. Down-regulation of the phosphatidylinositol 3-kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation and trascriptional activity of retinoic acid receptor γ2. J Biol Chem 2002; 277: 24859-62.
37. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Involvement of P13K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590-603.